Aryl hydrocarbon receptor gene polymorphisms affect lung cancer risk

被引:43
作者
Kim, Jin Hee
Kim, Heon
Lee, Kye Young
Kang, Jong-Won
Lee, Kwan-Hee
Park, So-Yeon
Yoon, Ho-Il
Jheon, Sang Hoon
Sung, Sook Whan
Hong, Yun-Chul
机构
[1] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Prevent Med, Cheongju 361763, Chungbuk, South Korea
[3] Konkuk Univ, Sch Med, Dept Internal Med, Seoul 143729, South Korea
[4] Inha Univ Hosp, Dept Occupat & Environm Med, Inchon 400103, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463707, Gyeongi Do, South Korea
[6] Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, Songnam 463707, Gyeongi Do, South Korea
[7] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 110799, South Korea
[8] SNUMRC, Inst Environm Med, Seoul 110799, South Korea
关键词
AhR; lung cancer risk; polymorphism; haplotype;
D O I
10.1016/j.lungcan.2006.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the rote of genetic polymorphisms of AhR related to the carcinogen metabolism and cell proliferation, genotypes of three AhR polymorphisms Ex1 + 185A > G, IVS7 + 33T > G and Ex10 + 501G > A were determined in 616 lung cancer cases and 616 lung cancer-free controls. When the effect of each AhR allele on lung cancer risk was evaluated, any AhR genotype did not show the association with lung cancer risk. However, when haptotypes were composed of three AhR SNP sites, non-smokers with GGG haplotype (adjusted OR = 1.7, 95% CI, 1.06-2.71) and smokers without GGG haplotype (adjusted OR = 2.5, 95% CI, 1.64-3.74 showed significantly increased risk of lung cancer compared to non-smokers without GGG haplotype. Moreover, smokers with GGG haplotype showed the highest risk (adjusted OR = 3.2, 95% CI, 2.10-4.74). Particularly, the synergistic effect between AhR haplotype and smoking was more apparent in squamous cell carcinoma (adjusted OR = 6.1, 95% CI, 2.53-14.68). This result suggests that haplotypes of AhR gene play an important role in the development of lung cancer and there is a synergistic interaction between AhR gene and smoking for lung cancer risk. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 28 条
[1]   CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor [J].
Anttila, S ;
Tuominen, P ;
Hirvonen, A ;
Nurminen, M ;
Karjalainen, A ;
Hankinson, O ;
Elovaara, E .
PHARMACOGENETICS, 2001, 11 (06) :501-509
[2]   Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma [J].
Berwick, M ;
Matullo, G ;
Song, YS ;
Guarrera, S ;
Dominguez, G ;
Orlow, I ;
Walker, M ;
Vineis, P .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3997-4001
[3]   Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population:: relationship with CYP1A1 inducibility and lung cancer [J].
Cauchi, S ;
Stücker, I ;
Solas, C ;
Laurent-Puig, P ;
Cénée, S ;
Hémon, D ;
Jacquet, M ;
Kremers, P ;
Beaune, P ;
Massaad-Massade, L .
CARCINOGENESIS, 2001, 22 (11) :1819-1824
[4]   Genetic polymorphism of the human cytochrome CYP2A13 in a French population:: implication in lung cancer susceptibility [J].
Cauffiez, C ;
Lo-Guidice, JM ;
Quaranta, S ;
Allorge, D ;
Chevalier, D ;
Cenée, S ;
Hamdan, A ;
Lhermitte, M ;
Lafitte, JJ ;
Libersa, C ;
Colombel, JF ;
Stücker, I ;
Broly, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (02) :662-669
[5]   Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors [J].
Currier, N ;
Solomon, SE ;
Demicco, EG ;
Chang, DLF ;
Farago, M ;
Ying, HQ ;
Dominguez, I ;
Sonenshein, GE ;
Cardiff, RD ;
Xiao, ZXJ ;
Sherr, DH ;
Seldin, DC .
TOXICOLOGIC PATHOLOGY, 2005, 33 (06) :726-737
[6]   The CYP3A4*1B allele increases risk for small cell lung cancer:: effect of gender and smoking dose [J].
Dally, H ;
Edler, L ;
Jäger, B ;
Schmezer, P ;
Spiegelhalder, B ;
Dienemann, H ;
Drings, P ;
Schulz, V ;
Kayser, K ;
Bartsch, H ;
Risch, A .
PHARMACOGENETICS, 2003, 13 (10) :607-618
[7]   Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals [J].
Denison, MS ;
Nagy, SR .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :309-334
[8]   Transcriptional activation of c-fos protooncogene by 17β-estradiol:: Mechanism of aryl hydrocarbon receptor-mediated inhibition [J].
Duan, RQ ;
Porter, W ;
Samudio, I ;
Vyhlidal, C ;
Kladde, M ;
Safe, S .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) :1511-1521
[9]   Identification of a motif within the 5' regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression [J].
Gillesby, BE ;
Stanostefano, M ;
Porter, W ;
Safe, S ;
Wu, ZF ;
Zacharewski, TR .
BIOCHEMISTRY, 1997, 36 (20) :6080-6089
[10]   POLYMORPHISMS OF HUMAN AH RECEPTOR GENE ARE NOT INVOLVED IN LUNG-CANCER [J].
KAWAJIRI, K ;
WATANABE, J ;
EGUCHI, H ;
NAKACHI, K ;
KIYOHARA, C ;
HAYASHI, S .
PHARMACOGENETICS, 1995, 5 (03) :151-158